Improving breathing in children with orthodontic treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates how orthodontic treatments, specifically mandibular advancement and maxillary expansion, can enhance upper airway volume and reduce respiratory effort in children with class II malocclusion. The study will analyze changes in airway dimensions and airflow resistance using a randomized crossover controlled trial design involving 90 children aged 8-14. Participants will be divided into groups receiving different treatment sequences, and their respiratory capabilities will be assessed using portable polysomnography. The goal is to establish a correlation between orthodontic interventions and improved breathing outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* children between the ages 8-14 years old (8-12 years old girls and 9-14 years old boys), presenting skeletal class II division 1 malocclusion with maxillary constriction

Exclusion Criteria:

* syndromic patients, previous ortho history, non-compliance, severe oral health issues (cavities, poor oral hygiene)

Where it's running

• University of Alberta
  Edmonton, Alberta, Canada Recruiting

Study contacts

• Principal investigator: Silvia G Capenakas, MSc — University of Alberta
• Study coordinator: Manuel Lagravere, PHD
• Email: manuel@ualberta.ca
• Phone: 7804927696

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How SpO₂ Changes During Reoxygenation After Breath-Holds

  This study tests how peripheral oxygen saturation readings from pulse oximeters behave during deliberate breath-holds and rapid reoxygenation in healthy adults.

  Recruiting Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Brussels · NCT07884500

• Berobenatide in adults with sleep apnea and obesity who don’t use a PAP machine

  This study tests berobenatide versus placebo in adults with moderate-to-severe obstructive sleep apnea and overweight or obesity who are not using PAP therapy.

  Recruiting at 3 sites Phase 3 Pfizer · Cullman, Alabama and 3 other locations · NCT07881757

• Berobenatide in adults with sleep apnea and obesity using a PAP machine

  This study tests berobenatide vs. placebo in adults with moderate to severe obstructive sleep apnea and overweight/obesity who use a PAP device.

  Recruiting at 6 sites Phase 3 Pfizer · Cullman, Alabama and 7 other locations · NCT07823608

• Daytime versus overnight titration for hypoglossal nerve stimulation

  We will test whether a daytime sleep test works as well as an overnight sleep test to fine-tune hypoglossal nerve stimulation for people with moderate to severe obstructive sleep apnea.

  Recruiting University Hospital, Antwerp · Edegem, Antwerp · NCT06559956

• Registry for patients with obstructive sleep apnea treated with hypoglossal nerve stimulation

  This study is collecting information from patients with moderate to severe obstructive sleep apnea who are using a new device called Inspire to see how well it works and how it helps them over five years.

  Recruiting at 2 sites University Hospital, Antwerp · Edegem, Antwerp and 1 other locations · NCT06332404

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.